According to Ypsomed's latest financial reports the company's current EPS (TTM) is โน546.70. In 2024 the company made an earnings per share (EPS) of โน546.70 an increase over its 2023 EPS that were of โน359.30.
Year | EPS | Change |
---|---|---|
2024 | โน546.70 | 52.16% |
2023 | โน359.30 | 110.93% |
2022 | โน170.34 | 307.14% |
2021 | โน41.84 | -49.58% |
2020 | โน82.97 | -79.79% |
2019 | โน410.59 | 10.54% |
2018 | โน371.44 | 18.22% |
2017 | โน314.18 | 24.64% |
2016 | โน252.07 | 84.88% |
2015 | โน136.35 | 30.72% |
2014 | โน104.31 | 790.09% |
2013 | โน11.72 | -81.6% |
2012 | โน63.67 | 58.82% |
2011 | โน40.09 | -37.57% |
2010 | โน64.21 | -63.35% |
2009 | โน175.22 | -14.15% |
2008 | โน204.10 | 1106.25% |
2007 | โน16.92 | -94.79% |
2006 | โน325.04 | 30.04% |
2005 | โน249.96 | 195.59% |
2004 | โน84.56 | -99.97% |
2003 | โน2,99,346 | 611303.59% |
2002 | โน48.96 |